ALACT — Acticor Biotech SA Cashflow Statement
0.000.00%
Last trade - 00:00
- €51.45m
- €50.55m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final |
Net Income/Starting Line | -5.05 | -7.65 | -12.6 | -15.9 |
Depreciation | ||||
Non-Cash Items | 0.115 | 0.281 | 1.18 | 0.941 |
Unusual Items | ||||
Other Non-Cash Items | ||||
Changes in Working Capital | 0.16 | 0.491 | -2.41 | 2.75 |
Change in Accounts Receivable | ||||
Change in Accounts Payable | ||||
Net Change in Other Assets & Liabilities | ||||
Other Operating Cash Flow | ||||
Cash from Operating Activities | -4.28 | -6.74 | -13.8 | -12.1 |
Capital Expenditures | -0.017 | -0.053 | -0.013 | -0.006 |
Purchase of Fixed Assets | ||||
Other Investing Cash Flow Items | 0.343 | 0 | 0.001 | -0.06 |
Sale of Fixed Assets | ||||
Sale/Maturity of Investment | ||||
Purchase of Investments | ||||
Other Investing Cash Flow | ||||
Cash from Investing Activities | 0.326 | -0.053 | -0.012 | -0.066 |
Financing Cash Flow Items | — | -0.001 | -0.424 | 1.93 |
Other Financing Cash Flow | ||||
Net Issuance / Retirement of Stock | ||||
Net Issuance / Retirement of Debt | ||||
Cash from Financing Activities | 6.64 | 1.5 | 17.5 | 7.42 |
Beginning Cash Balance | ||||
Ending Cash Balance | ||||
Net Change in Cash | 2.69 | -5.29 | 3.76 | -4.75 |